跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,337 条关于
“Classical Pathway”
全部
7,337
临床试验
2,288
药物
83
机构
18
资讯
4,948
去年
ANX007 Shows Promise in Preserving Vision in Dry AMD Patients with Geographic Atrophy
2年前
Annexon's ANX007 Shows Promise in Protecting Vision in Geographic Atrophy
去年
Dianthus Therapeutics Completes Enrollment in Phase 2 MaGic Trial for Generalized Myasthenia Gravis Treatment
去年
Ruxoprubart Receives FDA IND Clearance for Phase II Trials in IgAN and Dermatomyositis
去年
Ruxoprubart Shows Promising Phase II Results as Novel Monotherapy for Paroxysmal Nocturnal Hemoglobinuria
去年
Annexon Presents Phase 2 ARCHER Data Demonstrating ANX007's Vision and Photoreceptor Protection in Geographic Atrophy
3个月前
China Approves First Class 3.1 Classical Formula Drug Zhenwu Tang Granules, Marking TCM Modernization Milestone
去年
Sanofi's SAR446597 Gene Therapy Receives FDA Fast Track Designation for Geographic Atrophy Treatment
去年
Hesperos' Human-on-a-Chip Technology Supports Phase II Trial of DNTH103 for Generalized Myasthenia Gravis
去年
Annexon to Present Promising Data on ANX007's Neuroprotective Effects in Geographic Atrophy at Major Ophthalmology Conferences
第 1 页,共 495 页
上一页
下一页